chrX-154706415-CAAAA-C
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_001081573.3(GAB3):c.1069+5810_1069+5813delTTTT variant causes a intron change involving the alteration of a non-conserved nucleotide. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001081573.3 intron
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001081573.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GAB3 | MANE Select | c.1069+5810_1069+5813delTTTT | intron | N/A | NP_001075042.1 | Q8WWW8-2 | |||
| GAB3 | c.1066+5810_1066+5813delTTTT | intron | N/A | NP_542179.1 | Q8WWW8-1 | ||||
| GAB3 | c.1069+5810_1069+5813delTTTT | intron | N/A | NP_001269212.1 | Q8WWW8-3 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GAB3 | TSL:1 MANE Select | c.1069+5810_1069+5813delTTTT | intron | N/A | ENSP00000399588.2 | Q8WWW8-2 | |||
| GAB3 | TSL:1 | c.1066+5810_1066+5813delTTTT | intron | N/A | ENSP00000358588.3 | Q8WWW8-1 | |||
| GAB3 | TSL:1 | n.617-6360_617-6357delTTTT | intron | N/A |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 93552Hom.: 0 Cov.: 0
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 93552Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 20596
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.